OCUPHIRE PHARMA

Ocuphire Pharma is a clinical-stage biopharmaceutical company focuses on the development and commercialization of therapies to treat patients with a variety of ophthalmic disorders. It is currently focused on providing a novel once-daily eye drop treatment option, Nyxol, to treat multiple front-of-the-eye disorders, including night vision disturbances, glaucoma, pharmacologically-induced mydriasis, and presbyopia. Nyxol eye drops are an investigational 505(b)(2) drug candidate in late-stage cl... inical development with over a decade of safety and efficacy data from Phase 1 and 2 trials. Part of their strategy is to explore opportunities to acquire additional ophthalmic assets for both the front and the back of the eyes and to seek strategic partners for global commercialization. The company was founded in 2018 and is headquartered in Farmington Hills, Michigan.

#SimilarOrganizations #People #Financial #Website #More

OCUPHIRE PHARMA

Social Links:

Linkedin

Industry:

Biopharma Biotechnology Pharmaceutical

Founded:

2018-02-01

Address:

Farmington Hills, Michigan, United States

Country:

United States

Website Url:

http://www.ocuphire.com

Total Employee:

1+

Status:

Active

Contact:

(248) 681-9815

Email Addresses:

[email protected]

Total Funding:

24.56 M USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Font API Apple Mobile Web Clips Icon ReCAPTCHA Cloudflare Cloudflare Network Error Logging Cloudflare SSL ReCAPTCHA V2 CloudFront

Similar Organizations

day-one-biopharmaceuticals-logo

Day One Biopharmaceuticals

Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.

edgewise-therapeutics-logo

Edgewise Therapeutics

Edgewise Therapeutics is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization.

Current Advisors List

alan-meyer_image

Alan Meyer Board of Director @ Ocuphire Pharma
Board_member

Current Employees Featured

mina-patel-sooch_image

Mina Patel Sooch
Mina Patel Sooch Co-founder & CEO @ Ocuphire Pharma
Co-founder & CEO

alan-meyer_image

Alan Meyer
Alan Meyer Co-Founder @ Ocuphire Pharma
Co-Founder

sean-ainsworth_image

Sean Ainsworth
Sean Ainsworth Director @ Ocuphire Pharma
Director
2018-04-01

Founder

alan-meyer_image

Alan Meyer

mina-patel-sooch_image

Mina Patel Sooch

Stock Details

Company's stock symbol is NASDAQ:OCUP

Acquisitions List

Date	Company	Article	Price
2020-06-17	Rexahn Pharmaceuticals	Rexahn Pharmaceuticals acquired by Ocuphire Pharma	N/A

Investors List

altium-capital_image

Altium Capital

Altium Capital investment in Post-IPO Equity - Ocuphire Pharma

lincoln-park-capital-fund_image

Lincoln Park Capital Fund

Lincoln Park Capital Fund investment in Post-IPO Equity - Ocuphire Pharma

ayrton-capital_image

Ayrton Capital

Ayrton Capital investment in Post-IPO Equity - Ocuphire Pharma

district-2-capital_image

District 2 Capital

District 2 Capital investment in Post-IPO Equity - Ocuphire Pharma

national-eye-institute_image

National Eye Institute

National Eye Institute investment in Grant - Ocuphire Pharma

biosciences-research-and-commercialization-center-brcc_image

Biosciences Research and Commercialization Center (BRCC)

Biosciences Research and Commercialization Center (BRCC) investment in Seed Round - Ocuphire Pharma

blue-water-angels_image

Blue Water Angels

Blue Water Angels investment in Seed Round - Ocuphire Pharma

michigan-angel-fund_image

Michigan Angel Fund

Michigan Angel Fund investment in Seed Round - Ocuphire Pharma

first-capital-fund_image

First Capital Fund

First Capital Fund investment in Seed Round - Ocuphire Pharma

belle-capital_image

BELLE Capital

BELLE Capital investment in Seed Round - Ocuphire Pharma

Official Site Inspections

http://www.ocuphire.com Semrush global rank: 2.23 M Semrush visits lastest month: 8.64 K

Host Informations
Whois Informations

Loading ...

More informations about "Ocuphire Pharma" on Search Engine